SIGA Siga Technologies Inc.

SIGA Announces Public Health Agency of Canada Intent to Purchase Up To 33,300 Courses of Oral TPOXX®

SIGA Announces Public Health Agency of Canada Intent to Purchase Up To 33,300 Courses of Oral TPOXX®
EN
08/10/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Siga Technologies Inc.

 PRESS RELEASE

SIGA Declares Special Cash Dividend of $0.60 Per Share

SIGA Declares Special Cash Dividend of $0.60 Per Share NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on the company’s common stock. The amount of this dividend is consistent with the level of the special dividend declared in April 2025. The dividend is payable on April 23, 2026, to shareholders of record at the close of business on April 7, 2026. “Today’s announcement of a special cash dividend reflects th...

 PRESS RELEASE

SIGA Reports Financial Results for Three and Twelve Months Ended Decem...

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update Generated TPOXX Product Revenues of $88 Million in 2025 Received $13 Million International Procurement Order for Oral TPOXX in January 2026  Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ended December 31, 2025. “In 2025, we continued to advance SIGA's key long-term priorit...

 PRESS RELEASE

SIGA to Host Business Update Call on March 10, 2026, Following Release...

SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, March 10, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Rel...

 PRESS RELEASE

SIGA Reports Financial Results for Three and Nine Months Ended Septemb...

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025 Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2025. “We continue to advance SIGA's key priorities while generating $86 million in product revenues and $33 million in pre-tax operating income for the first nine months of 2025," stated Diem Nguyen, Chief Executive Officer. " As we look f...

 PRESS RELEASE

SIGA to Host Business Update Call on November 6, 2025 Following Releas...

SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, November 6, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Inves...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch